Guangzhou
Guangzhou
Guangzhou, Other (Non U.s.), China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RGL-270 + ICI in Advanced NSCLC | non-small cell lung carcinoma | Recruiting | Not applicable | 2026-06-30 | NCT07652125 | |
| Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 2 | 2026-02-04 | NCT07386158 | |
| Tissue-resident Immune Cell Subsets in aGVHD | Acute Graft-versus-Host Disease; Hematopoietic Stem Cell Transplantation | Recruiting | Not stated | 2024-11-27 | NCT06708507 | |
| Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma | Locally Advanced Nasopharyngeal Carcinoma | Recruiting | Phase 3 | 2023-05-16 | NCT05860868 |